English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 16 January 2019, 10:30 HKT/SGT

Source: Holista CollTech Ltd
Two Malaysian Companies to Develop Breakthrough Low GI Roti Canai

PERTH / KUALA LUMPUR, Jan 16, 2019 - (ACN Newswire) - Food ingredient specialist Holista CollTech Ltd (ASX:HCT, "Holista") has partnered Bursa Malaysia-listed Kawan Food Berhad ("Kawan Food") to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets.

Holista, which is listed in Australia and headquartered in Petaling Jaya, will use its proprietary mix of ingredients trademarked as GI Lite to develop a range of low-glycemic index ("low-GI") Indian flatbreads with Kawan Food - Malaysia's largest manufacturer and leading exporter of frozen Asian delicacies worldwide.

GI Lite added to Kawan Food range of products is expected to add up to AU$4 million to Holista's top line this year. The low-GI roti canai will be sold in Malaysia by April 2019, while sales to U.S. consumers are expected to commence in June 2019.

GI Lite has had a favorable sensory testing by Kawan Food, and Kawan Food is now starting low GI testing. The GI indicates the rate at which foods containing carbohydrates raise human blood sugar levels, with a lower score indicating healthier food. A diet high in carbohydrates is linked to diabetes, heart disease, obesity, poor energy levels, food cravings and drowsiness.

Based on Holista's previous laboratory trials, the companies expect to produce roti canai with a GI range. Holista is targeting the same results it achieves with flatbread, levels being about 40% lower than the current global average reading of 70 for flatbreads. The low-GI roti canai will also have lower fat content. Research and product trials are planned to begin this month. The testing will be done in in the University of Sydney as per international standards for Glycemic Index.

Kawan Food is a major supplier of frozen ethnic food with main product categories such as bakery, bun, chapatti, dessert, finger food, frozen vegetable, paratha and spring roll pastry. It currently exports to approximately forty (40) countries including US, Canada, UK, France, Australia and United Arab Emirates ("UAE"). Kawan Food is listed on the Malaysian Stock Exchange. It has been since 2005.

Roti canai, a breakfast favorite and staple food in Malaysia, contains significant amounts of calories and fats, exacerbating the existing problem of obesity in the country. According to the Economic Intelligence Unit, Malaysia is Asia's most obese nation with a 13.3% obesity rate.

Dato' Dr. Rajen Manicka, Managing Director and CEO of Holista, said: "We are excited to announce our partnership with Kawan Food, a home-grown producer and supplier of some of Malaysia's favourite food. Our low-GI versions of this popular staple food will help to address the growing problem of obesity and diabetes in Malaysia and abroad."

Holista's clean-label (all-natural) formula comprises a blend of okra, barley, lentils and fenugreek. When mixed with white flour, it lowers the GI reading of the final product without compromising taste or texture.

Mr. Timothy Tan, Managing Director of Kawan Food, said, "We are proud to work with Holista to be the first in the world to offer healthy flatbreads such as roti canai, effectively carving out a new niche in the food ingredients sector in Malaysia and beyond."

For further information, please contact:

Corporate Affairs & Business Opportunities
Dr Rajen Manicka: [email protected]
General Enquiries: [email protected]

283 Rokeby Road
Subiaco WA 6008
P: +61 8 6141 3500 ; F: +61 8 6141 3599

12th Floor, Amcorp Trade Centre, PJ Tower
No. 18, Persiaran Barat off Jalan Timur
46000, Petaling Jaya, Malaysia
P: +603 7965 2828 ; F: +603 7965 2777

Media and Investor Relations Enquiries
WeR1 Consultants Pte Ltd
3 Phillip Street #12-01
Singapore 048693
E: [email protected]; P: +65 67374844

About Holista CollTech Ltd

Holista CollTech Ltd (Holista) is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products and leads in research on herbs and food ingredients.

Holista, listed on the Australia Securities Exchange, researches, develops, manufactures and markets "health-style" products to address the unmet and growing needs of natural medicine. Holista's suite of ingredients is capable of serving the industry to provide low-GI baked products, low sodium salt, low fat fried foods and low calories sugar without compromise in taste, odour and mouth feel. It is the only company to produce sheep (ovine) collagen using patented extraction methods.

Full press release (PDF): http://www.acnnewswire.com/clientreports/598/20191601_HCT_Kawan_Food.pdf

Topic: Press release summary
Sectors: Food & Beverage, Daily News, BioTech, Healthcare & Pharm, Cosmetics & Spec.Chem
From the Asia Corporate News Network

Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Holista CollTech Ltd Releated News
Oct 21, 2020 21:00 HKT/SGT
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Oct 1, 2020 15:00 HKT/SGT
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread
Apr 21, 2020 06:30 HKT/SGT
Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate
Apr 3, 2020 17:00 HKT/SGT
Skin Elements Enters Binding Agreement with Holista Colltech To Launch All Natural Skin-Friendly Sanitiser
Feb 20, 2020 16:00 HKT/SGT
Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets
More news >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575